For Immediate Release

2017.08.31

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Sunao Manabe, Representative Director, President and COO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com

Announcement regarding today’s media report

TOKYO, Japan (August 31, 2017) - It was today reported by Nikkei Business that Daiichi Sankyo Company Limited received an acquisition offer from AstraZeneca. However, this is not the fact.